Date: February 1, 2012 (Wednesday)

Time: 10:00-12:00

Place: Yang-Ming University

 

Speakers

Investigation of Stemness Signatures and Tumor-initiating Property in Cancers

Dr. Chiou, Shih-Hwa (邱士華)

Professor, National Yang-Ming University

 

Microfluidic Biochip for the Label-Free Detection & Retrieval of CTCs – From bench to bedside

Dr. Chwee Teck LIM (林水德)

Professor, National University of Singapore

 

CaptorTM Demonstration

Label-free, microfiltration system for isolation, enumeration, and retrieval of circulating tumor cells (CTCs)

By Abnova

Abnova

+886-2-87511888

sales@abnova.com

Abnova has established a comprehensive portfolio of fully integrated solutions to address the needs of the in vitro diagnostic (IVD) industry. Abnova provides its partners and customers access to the technologies, products, and services relating to circulating rare cells, circulating exosomes, and circulating cell-free RNA for early to metastatic to recurrent disease and treatment diagnosis, prediction, guidance, and monitoring. Abnova facility is for proprietary bioreagent and high-throughput automation development and manufacturing for clinical trials and IVD commercialization. (www.abnova.com)